Clínica Baviera, S.A. (FRA:D9Z)

Market Cap	862.58M +24.4%
Revenue (ttm)	320.67M +11.0%
Net Income	45.95M +17.5%
EPS	2.87 +17.6%
Shares Out	n/a
PE Ratio	18.53
Forward PE	n/a
Dividend	1.27 (2.39%)
Ex-Dividend Date	Jun 10, 2026

Volume	9
Open	53.20
Previous Close	54.40
Day's Range	53.20 - 53.20
52-Week Range	40.10 - 61.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 26, 2026

About Clínica Baviera

Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal disease, dry eye, strabismus, pediatric ophthalmology, glaucoma, neuro-ophthalmological, disorders, and blepharoplasty treatments. It also provides external and internal consultations, surgery treatments, and rehabilitation services. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and changed its name to Clínic...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1992
• Employees: 2,009
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: D9Z

Financial Performance

In 2025, Clínica Baviera's revenue was 304.91 million, an increase of 14.75% compared to the previous year's 265.72 million. Earnings were 42.06 million, an increase of 4.62%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error